Pfizer pulls the plug on weight loss drug
Pfizer capitalized on COVID-19, but obesity is proving to be a tougher animal. Why it matters: For pharmaceutical companies, health crises are opportunities. And for those that can crack the code, weight-loss drugs are shaping up to be big business.